- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
Nine working papers by Srikant M. Datar and colleagues explore technologies pioneered during the late 20th century that US internists say have greatly improved patient care.
- 16 Apr 2019
- Working Paper Summaries
Can Biometric Tracking Improve Healthcare Provision and Data Quality? Experimental Evidence from Tuberculosis Control in India
This paper shows the benefits of biometric technology for strengthening service delivery and improving reliability of government data. The technology improved productivity of health workers operating tuberculosis treatment centers and decreased misreporting.
- 31 Jul 2018
- Working Paper Summaries
How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants
This analysis examines how a surge in liability risk faced by upstream suppliers of general purpose technologies (polymers) affected downstream innovation in implant technologies. Implant patenting dropped by 36 percent relative to non-implant technologies.
- 12 Jun 2018
- Research & Ideas
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
Pharmaceutical companies are criticized for not producing more breakthrough drugs. But new research by Joshua Krieger and colleagues shows that, given a financial windfall, drug giants turn on the innovation. Open for comment; Comment(s) posted.
- 08 Mar 2018
- Cold Call Podcast
Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?
Ariel Stern discusses her recent case study about creating a new type of clinical trial designed to deliver life-enhancing drugs to patients more quickly. Open for comment; Comment(s) posted.
- 11 Nov 2015
- Working Paper Summaries
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules
By tracing the often-circuitous path from National Institutes of Health (NIH) funding to patented innovations, this research examines the effects of public science on private sector innovation in the life sciences.
- 05 Nov 2009
- Research & Ideas
A Market for Human Cadavers in All but Name?
A shortage of cadavers has hampered medical education and training, a market that entrepreneurs are stepping forward to address. HBS professor Michel Anteby argues that scholars must learn more about the market dynamics of this uncomfortable subject in order to inform political debate. Closed for comment; 0 Comment(s) posted.
Who Guarantees Your Workplace Is Safe for Return?
Building health is today a top priority for owners and tenants, but how do we know our offices are safe to re-enter? John Macomber and Joseph Allen offer best practices. Open for comment; Comment(s) posted.